Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?
OBJECTIVE
To assess the effect of histopathological lesion characteristics on the sensitivity of magnetic resonance imaging (MRI) for per-lesion identification of extracapsular extension (ECE) of prostate cancer.


METHODS
The study included 176 patients (median age 58.9 years, range 38-77) who underwent endorectal MRI before radical prostatectomy between January 2001 and July 2004, had no previous treatment and had whole-mount step-section pathological specimens showing at least one capsule-abutting lesion. The likelihood of ECE of capsule-abutting lesions was retrospectively scored from 1 to 5 based on radiologists' prospective MRI interpretations. Generalized estimating equation regression models were used to determine the effect of the following histological variables on the sensitivity of MRI for identifying ECE of capsule-abutting lesions: maximum diameter, largest perpendicular diameter (LPD), bi-dimensional diameter product, Gleason grade, and zonal extent.


RESULTS
On histopathology, 339 capsule-abutting lesions were found, including 54 with ECE. MRI correctly identified ECE in 36/54 capsule-abutting lesions, including nine of 18 with focal ECE and 27/36 with established ECE, giving sensitivities (95% confidence interval) of 67 (53-78)%, 50 (27-73)% and 75 (58-87)%, respectively. MRI incorrectly identified ECE in 27/285 (9%) capsule-abutting lesions without ECE. MRI sensitivity for per-lesion ECE identification was significantly associated only with histopathological LPD (P = 0.009). Fifty-one patients (29%) had ECE. MRI had a sensitivity (95% confidence interval) of 69 (54-81)% and specificity of 90 (83-94)% for per-patient ECE identification.


CONCLUSIONS
The sensitivity of MRI in per-lesion identification of prostate cancer ECE is significantly associated with the lesion LPD at histopathology.
Wang
Liang
L
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Akin
Oguz
O
Mazaheri
Yousef
Y
Ishill
Nicole M
NM
Kuroiwa
Kentaro
K
Zhang
Jingbo
J
Hricak
Hedvig
H
D000328:Adult; D000368:Aged; D004812:Epidemiologic Methods; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods* / Q000592:standards; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D011467:Prostate / Q000473:pathology* / Q000601:surgery; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000601:surgery
J Clin Oncol. 2004 Jun 1;22(11):2141-9
15169800
J Urol. 2002 Nov;168(5):2011-5
12394697
Mod Pathol. 2005 Jul;18(7):886-90
15803186
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):665-71
18760545
Infirm Fr. 1981 Feb;(222):26, 28
6907191
Radiographics. 2004 Oct;24 Suppl 1:S167-80
15486239
Cancer. 1999 Jun 15;85(12):2630-7
10375112
J Urol. 2007 Dec;178(6):2260-7
17936815
Radiology. 1994 Nov;193(2):333-9
7972739
AJR Am J Roentgenol. 2007 Jan;188(1):84-90
17179349
Cancer. 2004 Jun 15;100(12):2655-63
15197809
Acta Radiol. 2001 Jul;42(4):348-54
11442457
Urology. 2000 Mar;55(3):382-6
10699615
Radiology. 2007 Apr;243(1):28-53
17392247
Eur Radiol. 2002 Sep;12(9):2294-302
12195484
J Urol. 1994 Nov;152(5 Pt 1):1520-5
7523710
Biometrics. 1992 Jun;48(2):577-85
1637980
Radiology. 1991 Mar;178(3):797-802
1994421
Radiology. 2007 Oct;245(1):176-85
17717328
J Urol. 2002 Feb;167(2 Pt 1):528-34
11792912
Radiology. 1997 Mar;202(3):697-702
9051019
Hum Pathol. 1998 Aug;29(8):856-62
9712429
Mod Pathol. 2004 Mar;17(3):349-59
14765206
J Urol. 2003 Dec;170(6 Pt 1):2292-5
14634399
AJR Am J Roentgenol. 1996 Apr;166(4):845-52
8610561
Urology. 2001 Apr;57(4):721-6
11306390